When is the hand-foot-mouth vaccine?

The HFMD vaccine is generally recommended for children aged 6 months to 5 years as early as possible. From 6 months of age, the child's range of activities gradually increases, and the opportunity to contact the outside environment and people increases, and the risk of infection increases. Vaccination as early as possible allows children to obtain immune protection before the onset of the disease and reduces the possibility of disease. Current HFMD vaccines target enterovirus 71.(EV 71), which is one of the main pathogens causing severe hand, foot and mouth disease. Vaccination can effectively prevent severe cases caused by EV 71 infection and reduce health hazards caused by severe hand, foot and mouth disease, such as encephalitis, pulmonary edema and other serious complications. A large number of clinical research data show that hand, foot and mouth vaccine has good protective efficacy. After vaccination, the incidence of HFMD can be reduced to a certain extent. Even if infection occurs, the symptoms are often mild and the course of disease is short, reducing the adverse effects of the disease on children's body and life. After rigorous clinical trials and post-marketing monitoring, the safety of HFMD vaccine is reliable. Common adverse reactions are usually mild and short-lived, such as local pain, redness, fever, etc., which can generally be relieved by themselves. Very few serious adverse reactions may occur, but the incidence rate is very low. Generally, basic immunization requires 2 doses, with an interval of 1 month. Vaccination according to the prescribed procedures can ensure that the vaccine fully functions, produces sufficient antibody levels, and provides lasting and stable protection. At the same time, parents should pay attention to taking their children to vaccinate on time, and do not delay or miss the vaccination at will.